Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07AHC
|
|||
Former ID |
DNC009144
|
|||
Drug Name |
LITOXETINE
|
|||
Synonyms |
Litoxetine; 86811-09-8; 4-(2-Naphthylmethoxy)piperidine; UNII-9980ST005G; CHEMBL471036; 9980ST005G; Litoxetinum; Litoxetina; Litoxetine [INN]; Litoxetinum [INN-Latin]; Litoxetina [INN-Spanish]; AC1L23OW; SCHEMBL119884; ZINC3647; CTK3E8854; DTXSID30235828; BDBM50278564; 4-(naphthalen-2-ylmethoxy)piperidine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Mood disorder [ICD-11: 6A60-6E23] | Phase 3 | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H19NO
|
|||
Canonical SMILES |
C1CNCCC1OCC2=CC3=CC=CC=C3C=C2
|
|||
InChI |
1S/C16H19NO/c1-2-4-15-11-13(5-6-14(15)3-1)12-18-16-7-9-17-10-8-16/h1-6,11,16-17H,7-10,12H2
|
|||
InChIKey |
MJJDYOLPMGIWND-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 86811-09-8
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | 5-HT 3 receptor (5HT3R) | Target Info | Modulator | [2] |
Serotonin transporter (SERT) | Target Info | Modulator | [2] | |
KEGG Pathway | Serotonergic synapse | |||
NetPath Pathway | TCR Signaling Pathway | |||
Panther Pathway | 5HT1 type receptor mediated signaling pathway | |||
5HT2 type receptor mediated signaling pathway | ||||
5HT3 type receptor mediated signaling pathway | ||||
5HT4 type receptor mediated signaling pathway | ||||
WikiPathways | Monoamine Transport | |||
SIDS Susceptibility Pathways | ||||
NRF2 pathway | ||||
Synaptic Vesicle Pathway | ||||
Serotonin Transporter Activity |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001264) | |||
REF 2 | Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT3 receptor antagonist and antiemetic properties. Eur J Pharmacol. 1993 Mar 2;232(2-3):139-45. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.